HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 206 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilienceNext articleLayoffs don’t have to feel inhumane RELATED ARTICLES Strategy CDs Are Making an Unexpected Comeback. The Reason Isn’t Just Nostalgia Strategy A Bad Registered Agent Can Cost You Hundreds of Dollars — or Your Entire Business. Here’s How to Find a Good One. Strategy 5 ways leaders can harness brain chemistry for happier and more productive teams Strategy Skin cancer detection tools powered by AI are improving. Not everyone is benefitting Must Read Separate Your Bills Account From Your Spending Account Finance Rebalancing Your Portfolio Once a Year Keeps Your Risk in Check Finance A Robo-Advisor Is the Lowest-Friction Way to Start Investing Finance Start Investing Early – The Gap Between 25 and 35 Is Enormous Finance CDs Are Making an Unexpected Comeback. The Reason Isn’t Just Nostalgia Strategy